MFDS — authorised 27 November 2013
- Marketing authorisation holder: VIFOR FRESENIUS
- Status: likely_approved
🇰🇷 Ferrlecit in South Korea
MFDS authorised Ferrlecit on 27 November 2013
Marketing authorisation
Ferrlecit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Ferrlecit approved in South Korea?
Yes. MFDS authorised it on 27 November 2013.
Who is the marketing authorisation holder for Ferrlecit in South Korea?
VIFOR FRESENIUS holds the South Korean marketing authorisation.